iPLATO’s evidence based mobile health solutions have proven to transform patient services and reduce health inequalities across populations. We work closely with national and regional health authorities as well as healthcare providers (large and small), pharmaceutical companies, pharmacies and health insurers using mHealth to, measurably, improve outcomes.
Harnessing the potential of new technology often includes process redesign, technology customisation, integration and change management. To deliver end-to-end patient service transformation, therefore, iPLATO’s solutions include a comprehensive set of professional and technology services.
Wellness
iPLATO has extensive experience in the area of primary prevention. Following a tried and tested methodology, iPLATO’s consultants work with GPs and pharmacists to collect and validate data, engage and enroll patients and, if necessary, support adherence and persistence to treatment.
Here are some examples:
Diagnosis
iPLATO’s solutions have proven to maximize the benefits of diagnostics services. iPLATO can help in three important ways. First, we can enable population-wide risk stratification. Second, we support patient self diagnosis or pre-screening. Finally, we can increase the use of existing screening facilities and equipment or, if required, bring additional diagnostics services to the community as well as follow-up.
Here are some examples:
Long Term Condition Management
With demand on health services consistently raising there has been a growing enthusiasm for telehealthcare services. mHealth is an attractive sub-segment of telehealthcare. In fact, by leveraging existing networks and devices, iPLATO has proven that mHealth can transform telehealthcare. Operating at much lower cost, mHealth allows technology enabled remote care services to reach to more people.
Examples: